Physician profile
Monica Martinez
NPI 1912671298
$3,967.58
in general payments reported to CMS, 2019-2025
41 companies · $826 in 2025
The $826 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,168 · 2023: $1,641 · 2024: $334 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,610 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,609.82 |
| Education | $190.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $599.60 | 2022-2025 | Evenity, Prolia, Otezla |
| Novo Nordisk INC | $491.86 | 2022-2025 | Wegovy |
| Abbvie INC. | $377.99 | 2022-2025 | |
| Astellas Pharma US INC | $228.82 | 2023-2025 | Veozah |
| Lilly USA, LLC | $159.37 | 2022-2023 | Mounjaro, Jardiance |
| Organon LLC | $148.23 | 2022-2025 | Nexplanon |
| Teva Pharmaceuticals USA, INC. | $134.20 | 2022-2024 | Austedo Xr |
| Inspire Medical Systems, INC. | $126.40 | 2023 | Inspire |
| Abbott Laboratories | $125.00 | 2023 | Freestyle Libre 3 |
| Dexcom, INC. | $121.84 | 2023 | Dexcom G7 Gss (161) |
| Dynavax Technologies Corporation | $117.83 | 2022-2023 | Heplisav-B |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.88 | 2022-2023 | Trulance, Xifaxan |
| Janssen Pharmaceuticals, INC | $112.74 | 2022-2023 | Spravato, Xarelto |
| Pfizer INC. | $96.16 | 2022-2023 | |
| Exeltis, USA INC. | $88.15 | 2024-2025 | Slynd |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.